On the other hand, in MM, BM-MSCs display a lower proliferation rate and a reduced osteogenic capacity compared to normal MSCs, but these defects have been related to the reduced expression of several growth factor receptors, including EGFR, IGF1R, PDGFαR, and FGFR [18,19]. The gene discussed is EGFR; the disease is Miyoshi myopathy.